High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis

被引:1
|
作者
Gao, Yongyin [1 ]
Guan, Lizhao [2 ]
Jia, Ran [3 ,4 ]
Xiao, Wanyi [1 ]
Han, Youming [5 ]
Li, Yue [1 ]
Tang, Peng [1 ]
Yu, Zhentao [3 ,4 ]
Zhang, Hongdian [1 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy Tianjin, Tianjin 300060, Peoples R China
[2] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin 300070, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc, Shenzhen 518116, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen 518116, Peoples R China
[5] Tianjin Med Univ, Binhai Hosp, Gen Hosp, Tianjin 300456, Peoples R China
基金
中国国家自然科学基金;
关键词
Esophageal squamous cell carcinoma; PPFIA1; Bioinformatics analysis; Prognosis; Migration and invasion; CANCER; 11Q13; LIPRIN-ALPHA-1; AMPLIFICATION; GENES;
D O I
10.1186/s12885-023-10872-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPTPRF interacting protein alpha 1 (PPFIA1) is reportedly related to the occurrence and progression of several kinds of malignancies. However, its role in esophageal squamous cell carcinoma (ESCC) is unclear. This current study investigated the prognostic significance and biological functions of PPFIA1 in ESCC.MethodsOncomine, Gene Expression Profiling Interactive Analysis (GEPIA), and Gene Expression Omnibus (GEO) were used to investigate PPFIA1 expression in esophageal cancer. The relationship between PPFIA1 expression and clinicopathological characteristics and patient survival was evaluated in GSE53625 dataset, and verified in the cDNA array based on qRT-PCR and tissue microarray (TMA) dataset based on immunohistochemistry. The impact of PPFIA1 on the migration and invasion of cancer cells were investigated by wound-healing and transwell assays, respectively.ResultsThe expression of PPFIA1 was obviously increased in ESCC tissues versus adjacent esophageal tissues according to online database analyses (all P < 0.05). High PPFIA1 expression was closely related to several clinicopathological characteristics, including tumor location, histological grade, tumor invasion depth, lymph node metastasis, and tumor-node-metastasis (TNM) stage. High PPFIA1 expression was related to worse outcomes and was identified as an independent prognostic factor of overall survival in ESCC patients (GSE53625 dataset, P = 0.019; cDNA array dataset, P < 0.001; TMA dataset, P = 0.039). Downregulation of PPFIA1 expression can significantly reduce the migration and invasion ability of ESCC cells.ConclusionPPFIA1 is related to the migration and invasion of ESCC cells, and can be used as a potential biomarker to evaluate the prognosis of ESCC patients.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis
    Zhu, Xiaolei
    Jin, Huan
    Xia, Ziwei
    Wu, Xianxian
    Yang, Mingjian
    Zhang, Hongdian
    Shang, Xiaobin
    Cheng, Runfen
    Zhan, Zhongli
    Yu, Zhentao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 486 (02) : 571 - 576
  • [32] Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma
    Yamamoto, H
    Iku, S
    Itoh, F
    Tang, XF
    Hosokawa, M
    Imai, K
    CANCER, 2001, 91 (07) : 1324 - 1331
  • [33] High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
    He, Li-Ru
    Liu, Meng-Zhong
    Li, Bin-Kui
    Jia, Wei-Hua
    Zhang, Ying
    Liao, Yi-Ji
    Chen, Yang-Chao
    Zhang, Lan-Jun
    Guan, Xin-Yuan
    Zeng, Yi-Xin
    Kung, Hsiang-Fu
    Xie, Dan
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (01) : 138 - 147
  • [34] Mitochondrial energy metabolism correlates with an immunosuppressive tumor microenvironment and poor prognosis in esophageal squamous cell carcinoma
    Zhang, Zewei
    Jin, Gaowa
    Zhao, Juan
    Deng, Shuqin
    Chen, Feng
    Wuyun, Gaowa
    Zhao, Lei
    Li, Quanfu
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2023, 21 : 4118 - 4133
  • [35] Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma
    Nakade, Hiroshi
    Migita, Kazuhiro
    Matsumoto, Sohei
    Wakatsuki, Kohei
    Kunishige, Tomohiro
    Miyao, Shintaro
    Sho, Masayuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 446 - 455
  • [36] The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma
    Shibamoto, Misako
    Hirata, Hidenari
    Eguchi, Hidetoshi
    Sawada, Genta
    Sakai, Noritaka
    Kajiyama, Yoshiaki
    Mimori, Koshi
    ONCOLOGY LETTERS, 2017, 13 (03) : 1761 - 1766
  • [37] High stathmin 1 expression is associated with poor prognosis and chemoradiation resistance in esophageal squamous cell carcinoma
    Suzuki, Shigemasa
    Yokobori, Takehiko
    Altan, Bolag
    Hara, Keigo
    Ozawa, Daigo
    Tanaka, Naritaka
    Saicai, Makoto
    Sano, Akihiko
    Sohda, Makoto
    Bao, Halin
    Fukuchi, Minoru
    Miyazaki, Tatsuya
    Kaira, Kyoichi
    Asao, Takayuki
    Kuwano, Hiroyuki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (04) : 1184 - 1190
  • [38] PD1+ tumor associated macrophages predict poor prognosis of locally advanced esophageal squamous cell carcinoma
    Lu, Yufei
    Guo, Leiming
    Ding, Gaofeng
    FUTURE ONCOLOGY, 2019, 15 (35) : 4019 - 4030
  • [39] High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma
    Luo, Qiu-Yun
    Di, Tian
    Qiu, Miao-Zhen
    Xia, Zeng-Fei
    Du, Yong
    Lin, Run-Duan
    Yang, Li-Qiong
    Sun, Yu-Ting
    Yang, Da-Jun
    Sun, Jian
    Zhang, Lin
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [40] High Expression of Tetraspanin CD63 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma
    Matsumoto, Yasunori
    Otsuka, Ryota
    Nishioka, Yuri
    Toyozumi, Takeshi
    Sekino, Nobufumi
    Shiraishi, Tadashi
    Okada, Koichiro
    Kamata, Toshiki
    Iida, Shinichiro
    Morishita, Hiroki
    Makiyama, Tenshi
    Yamada, Masanari
    Matsubara, Hisahiro
    ONCOLOGY, 2025,